Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith
    7.
    发明授权
    Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith 有权
    通过测定与其相关的多种抗原来确定乳腺癌和黑素瘤的方法

    公开(公告)号:US06338947B1

    公开(公告)日:2002-01-15

    申请号:US09578378

    申请日:2000-05-25

    IPC分类号: G01N3353

    摘要: The invention relates to assays for determining breast cancer or melanoma. It has been found that the accuracy of such assays can be improved by assaying samples for three or more known tumor rejection antigen precursors. For breast cancer, the tumor rejection antigen precursors known as SCP-1, NY-ESO-1, and SSX-2 are assayed. For melanoma, SSX-2, NY-ESO-1, and MAGE-3 are assayed. Additional known tumor rejection antigen precursors can also be determined to confirm the assays. It is preferred to carry these out via polymerase chain reactions.

    摘要翻译: 本发明涉及用于确定乳腺癌或黑素瘤的测定法。 已经发现,通过测定三种或更多种已知的肿瘤排斥抗原前体的样品,可以提高这些测定的准确性。 对于乳腺癌,测定称为SCP-1,NY-ESO-1和SSX-2的肿瘤排斥抗原前体。 对于黑素瘤,测定SSX-2,NY-ESO-1和MAGE-3。 还可以确定另外已知的肿瘤排斥抗原前体以确认测定。 优选通过聚合酶链反应进行这些操作。